21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
62.09.Z - Activities related to programming, IT consulting, and related activities
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
68.31.Z - Real estate brokerage
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
73.20.Z - Market research and public opinion polling
78.30.Z - Employment activities
82.11.Z - Office administrative support activities and other business support services
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 3 | 5,2 | 1,5 | -71,5 |
Short time liabilities | 26,5 | 6,5 | 6,5 | 0,1 |
Other operating costs | 0 | 0,2 | 1,1 | 365,8 |
Income tax | -100 | |||
Equity capital | 427,6 | 431,4 | 432,9 | 0,3 |
Assets | 454,1 | 437,9 | 439,4 | 0,3 |
Net profit (loss) | 3 | 5,2 | 1,5 | -71,5 |
Cash | 1,6 | 3 | 2,3 | -22,7 |
Net income from sale | 0 | 0 | 0,1 | 88,1 |
Liabilities and provisions for liabilities | 26,5 | 6,5 | 6,5 | 0,1 |
Working assets | 31,3 | 15,2 | 15,6 | 2,7 |
Other income costs | 1,5 | 0,1 | 2,6 | 2300,7 |
Depreciation | 0 | 0 | 0 | -50,6 |
Basic operational activity income | 0,2 | |||
% | % | % | p.p. | |
Profitability of capital | 0,7 | 1,2 | 0,3 | -0,9 |
Equity capital to total assets | 94,2 | 98,5 | 98,5 | 0 |
Gross profit margin | 13 020 | 13 631 | 2061,5 | -11 569,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 425 839 | 61 969 | 32 984 | -28 985 |
Current financial liquidity indicator | 1.1826931238174438 | 2.3328466415405273 | 2.3915698528289795 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane